Home109820 • KOSDAQ
add
Genematrix Inc
Nakaraang pagsara
₩2,745.00
Sakop ng araw
₩2,705.00 - ₩2,780.00
Sakop ng taon
₩2,270.00 - ₩7,180.00
Market cap
56.29B KRW
Average na Volume
639.79K
P/E ratio
-
Dividend yield
-
Primary exchange
KOSDAQ
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
(KRW) | 2018info | Y/Y na pagbabago |
---|---|---|
Kita | 4.73B | -8.75% |
Gastos sa pagpapatakbo | 4.54B | 26.32% |
Net na kita | -3.11B | -111.37% |
Net profit margin | -65.61 | -131.67% |
Kita sa bawat share | — | — |
EBITDA | -2.46B | -71.80% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(KRW) | 2018info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 15.26B | 99.39% |
Kabuuang asset | 31.52B | 77.64% |
Kabuuang sagutin | 20.12B | 247.02% |
Kabuuang equity | 11.40B | — |
Natitirang share | 16.03M | — |
Presyo para makapag-book | 4.06 | — |
Return on assets | -7.12% | — |
Return on capital | -7.86% | — |
Cash Flow
Net change in cash
(KRW) | 2018info | Y/Y na pagbabago |
---|---|---|
Net na kita | -3.11B | -111.37% |
Cash mula sa mga operasyon | -2.74B | -54.37% |
Cash mula sa pag-invest | -9.51B | -650.91% |
Cash mula sa financing | 16.36B | 17,898.17% |
Net change in cash | 4.11B | 11,968.54% |
Malayang cash flow | -1.28B | 17.07% |
Tungkol
GeneMatrix Inc is a Korean company servicing molecular diagnostics. The company is listed on KOSDAQ:109820.
Its main service is to diagnose DNA mutations based on its proprietary technology of restriction fragment mass polymorphism.
GeneMatrix is affiliated with the Seoul National University Medical Center, the largest oncology center in Korea. Wikipedia
Itinatag
2000
Website
Mga Empleyado
67